In a 4T1 breast cancer mouse model, the combination of stereotactic ablative radiotherapy and a cancer vaccine targeting fibroblast-activating protein-alpha (FAP-α) effectively suppressed metastatic growth 78. Here, FAP is linked to breast carcinoma.